{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:23:17Z","timestamp":1787584997897,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.amjms.2020.12.022","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T17:46:44Z","timestamp":1613152004000},"page":"635-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials"],"prefix":"10.1016","volume":"361","author":[{"given":"Daiquan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0001","first-page":"490","article-title":"High altitude illness","volume":"70","author":"Hartman-Ksyci\u0144ska","year":"2016","journal-title":"Przegl Epidemiol"},{"issue":"7","key":"10.1016\/j.amjms.2020.12.022_bib0002","first-page":"742","article-title":"Acute mountain sickness and ascent rates in trekkers above 2500m in the Nepali Himalaya","volume":"77","author":"Vardy","year":"2006","journal-title":"Aviat Space Environ Med"},{"issue":"4","key":"10.1016\/j.amjms.2020.12.022_bib0003","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/ham.2008.1008","article-title":"Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an observational study","volume":"9","author":"Karinen","year":"2008","journal-title":"High Alt Med Biol"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/ham.2010.1003","article-title":"Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro","volume":"11","author":"Jackson","year":"2010","journal-title":"High Alt Med Biol"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/ham.2009.1004","article-title":"Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 m","volume":"10","author":"Beidleman","year":"2009","journal-title":"High Alt Med Biol"},{"issue":"4","key":"10.1016\/j.amjms.2020.12.022_bib0006","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.amjms.2020.12.022_bib0007","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","first-page":"361","article-title":"Carbonic anhydrase inhibitors and high altitude illnesses","author":"Swenson","year":"2014"},{"issue":"2","key":"10.1016\/j.amjms.2020.12.022_bib0008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/ham.2011.1084","article-title":"Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis","volume":"13","author":"Kayser","year":"2012","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjms.2020.12.022_bib0009","doi-asserted-by":"crossref","first-page":"e6779","DOI":"10.1136\/bmj.e6779","article-title":"Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis","volume":"345","author":"Low","year":"2012","journal-title":"BMJ"},{"issue":"7256","key":"10.1016\/j.amjms.2020.12.022_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.321.7256.267","article-title":"Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review","volume":"321","author":"Dumont","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/152702904322963672","article-title":"A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630m)","volume":"5","author":"Carlsten","year":"2004","journal-title":"High Alt Med Biol Spring"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/ham.2007.1037","article-title":"Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness","volume":"9","author":"Kayser","year":"2008","journal-title":"High Alt Med Biol Spring"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0013","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.wem.2014.04.003","article-title":"Exercise limitation of acetazolamide at altitude (3459m)","volume":"25","author":"Bradwell","year":"2014","journal-title":"Wilderness Environ Med"},{"issue":"2","key":"10.1016\/j.amjms.2020.12.022_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148206","article-title":"Acute mountain sickness symptom severity at the south pole: the influence of self-selected prophylaxis with acetazolamide","volume":"11","author":"Harrison","year":"2016","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.amjms.2020.12.022_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"7414","key":"10.1016\/j.amjms.2020.12.022_bib0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0019","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/152702903321488979","article-title":"Efficacy of low-dose acetazolamide (125mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Basnyat","year":"2003","journal-title":"High Alt Med Biol Spring"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/ham.2006.7.17","article-title":"Acetazolamide 125mg BD is not significantly different from 375mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial","volume":"7","author":"Basnyat","year":"2006","journal-title":"High Alt Med Biol Spring"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0022","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/ham.2007.1073","article-title":"Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans","volume":"9","author":"Basnyat","year":"2008","journal-title":"High Alt Med Biol Fall"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.wem.2010.10.009","article-title":"Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group)","volume":"22","author":"Basnyat","year":"2011","journal-title":"Wilderness Environ Med"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0024","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1378\/chest.101.3.736","article-title":"The effects of acetazolamide on the ventilatory response to high altitude hypoxia","volume":"101","author":"Burki","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1378\/chest.14-0317","article-title":"Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude","volume":"147","author":"Caravita","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0026","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archinte.165.3.296","article-title":"Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial","volume":"165","author":"Chow","year":"2005","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.amjms.2020.12.022_bib0027","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0002-9343(87)90937-5","article-title":"A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis","volume":"83","author":"Ellsworth","year":"1987","journal-title":"Am J Med"},{"issue":"7443","key":"10.1016\/j.amjms.2020.12.022_bib0028","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bmj.38043.501690.7C","article-title":"Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)","volume":"328","author":"Gertsch","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.wem.2010.06.009","article-title":"Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT)","volume":"21","author":"Gertsch","year":"2010","journal-title":"Wilderness Environ Med"},{"issue":"7996","key":"10.1016\/j.amjms.2020.12.022_bib0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(76)91677-9","article-title":"The incidence, importance, and prophylaxis of acute mountain sickness","volume":"2","author":"Hackett","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjms.2020.12.022_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1580\/1080-6032-17.2.87","article-title":"Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial","volume":"17","author":"Hillenbrand","year":"2006","journal-title":"Wilderness Environ Med"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0032","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jama.1982.03330030034021","article-title":"Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation","volume":"248","author":"Larson","year":"1982","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjms.2020.12.022_bib0033","doi-asserted-by":"crossref","first-page":"200.e209","DOI":"10.1016\/j.amjmed.2017.05.034","article-title":"Budesonide versus acetazolamide for prevention of acute mountain sickness","volume":"131","author":"Lipman","year":"2018","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.amjms.2020.12.022_bib0034","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1580\/06-WEME-OR-062R2.1","article-title":"Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollag\u00fce (3696m) in northern Chile","volume":"18","author":"Moraga","year":"2007","journal-title":"Wilderness Environ Med"},{"issue":"10","key":"10.1016\/j.amjms.2020.12.022_bib0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/eurheartj\/ehs140","article-title":"Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure","volume":"34","author":"Parati","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.amjms.2020.12.022_bib0036","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.111.00707","article-title":"Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide","volume":"61","author":"Salvi","year":"2013","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.amjms.2020.12.022_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/ham.2008.1029","article-title":"Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness","volume":"9","author":"van Patot","year":"2008","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjms.2020.12.022_bib0038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ntt.2012.12.003","article-title":"Effects of acetazolamide on cognitive performance during high-altitude exposure","volume":"35","author":"Wang","year":"2013","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"10.1016\/j.amjms.2020.12.022_bib0039","first-page":"541","article-title":"Acetazolamide and dexamethasone in the prevention of acute mountain sickness","volume":"148","author":"Zell","year":"1988","journal-title":"West J Med"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/ham.2017.0164","article-title":"The 2018 Lake Louise acute mountain sickness score","volume":"19","author":"Roach","year":"2018","journal-title":"High Alt Med Biol"},{"issue":"9 Pt 1","key":"10.1016\/j.amjms.2020.12.022_bib0041","first-page":"872","article-title":"The environmental symptoms questionnaire: revisions and new filed data","volume":"51","author":"Sampson","year":"1980","journal-title":"Aviat Space Environ Med"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0042","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2466\/pms.1971.33.3.735","article-title":"Symptomatology subscales for the measurement of acute mountain sickness","volume":"33","author":"Stamper","year":"1971","journal-title":"Percept Mot Skills"},{"issue":"5","key":"10.1016\/j.amjms.2020.12.022_bib0043","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1708-8305.2012.00629.x","article-title":"Acetazolamide for the prevention of acute mountain sickness\u2013a systematic review and meta-analysis","volume":"19","author":"Ritchie","year":"2012","journal-title":"J Travel Med"},{"key":"10.1016\/j.amjms.2020.12.022_bib0044","doi-asserted-by":"crossref","unstructured":"Sridharan K., Sivaramakrishnan G. Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials. 2018;50(2):147\u2013155.","DOI":"10.1080\/07853890.2017.1407034"},{"key":"10.1016\/j.amjms.2020.12.022_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.05.003","article-title":"A randomized controlled trial of the lowest effective dose of acetazolamide for acute mountain sickness prevention","author":"Lipman","year":"2020","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.amjms.2020.12.022_bib0046","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.wem.2018.09.002","article-title":"Reduced acetazolamide dosing in countering altitude illness: a comparison of 62.5vs 125mg (the RADICAL Trial)","volume":"30","author":"McIntosh","year":"2019","journal-title":"Wilderness Environ Med"},{"issue":"3","key":"10.1016\/j.amjms.2020.12.022_bib0047","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/ham.2019.0007","article-title":"Day of ascent dosing of acetazolamide for prevention of acute mountain sickness","volume":"20","author":"Lipman","year":"2019","journal-title":"High Alt Med Biol"},{"issue":"12","key":"10.1016\/j.amjms.2020.12.022_bib0048","first-page":"1186","article-title":"Assessment of acute mountain sickness by different score protocols in the Swiss Alps","volume":"69","author":"Maggiorini","year":"1998","journal-title":"Aviat Space Environ Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:39:09Z","timestamp":1757702349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0002962921000604"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2020.12.022","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2020.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}